Paul McEwan
North America, New York, United States, New York
Description
Paul is a co–founder and currently serves as the Chief Scientific Officer of Kapa Biosystems, a company using protein evolution technology f...
Investor Profile
Paul McEwan has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Analytics, Biopharma.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Analytics
- Biopharma
- Health Diagnostics
- Pharmaceutical
- Biometrics
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
